Comparison of anxiety and depression levels of type 2 diabetes patients by treatment type

Abstract

Objective: Diabetes Mellitus is considered as a public health problem. It is a common chronic disease and the rate of anxiety and depression is higher than the general population. But, anxiety and depression accompanying diabetes are often unknown and therefore untreated. In this study, we aimed to investigate the relationship between anxiety and depression levels and the type of treatment.

Methods: Patients who were admitted to our hospital between May-October 2017 and diagnosed with Type 2 diabetes for at least 1 year were included in the study. A questionnaire consisting of sociodemographic and clinical data form and Hospital Anxiety and Depression Scale was used.

Results: The mean age of the patients was 59.3 ± 11.5 years. 34.2% of the participants were male. The mean age of the women was 59.35 years. 11.2% of the patients were university graduates. The duration of diabetes longer than 10 years was 55.1%. The patients with a body mass index of 30 and above accounted for 50.6% of the patients. The mean Hospital Anxiety and Depression Scale A values of the patients were 9.7 ± 2.8 and the mean Hospital Anxiety and Depression Scale D values were 9.5 ± 1.9. There was a statistically significant difference between mean Hospital Anxiety and Depression Scale A values (p <0.001) and Hospital Anxiety and Depression Scale A positivity rates (p = 0.002) according to gender. Mean Hospital Anxiety and Depression Scale A positivity and Hospital Anxiety and Depression Scale A positivity rates of women were higher than men. The mean Hospital Anxiety and Depression Scale A values (p = 0.019) and Hospital Anxiety and Depression Scale A positivity rates (p=0.004) of the patients who were living in the house with less than 3 people were found to be lower than those living with 3 people or more.

Conclusion: The risk of anxiety and depression is increased in type 2 diabetes patients compared to the general population. All patients with diabetes should be evaluated as a whole and depression and anxiety, which are at increased risk during this assessment process, should be considered.